Patents by Inventor Marilynn Larson

Marilynn Larson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genomic mammary amyloid a sequence
    Publication number: 20060024804
    Abstract: A genomic nucleotide sequence encoding Serum Amyloid A (SAA), isolated and purified from mammalian colostrum, is disclosed. Methods of use for the same in transgenic protocols is also disclosed.
    Type: Application
    Filed: April 4, 2002
    Publication date: February 2, 2006
    Inventors: Thomas McDonald, Marilynn Larson, Annika Weber
  • Mammary-associated serum amuloid a3 promoter sequences and used for same
    Publication number: 20050107315
    Abstract: Novel colostrum associated mammalian Serum Amyloid A (SAA) promoter sequences are disclosed. These promoters can be used in transgenic protocols for tissue specific expression and expression constructs, vectors and host cells are disclosed. Also the regulatory features of these promoters in colostrum associated SAA productions are exploited to treat disease states associated with or influenced by colostrum associated SAA production.
    Type: Application
    Filed: November 20, 2002
    Publication date: May 19, 2005
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Thomas McDonald, Marilynn Larson, Annika Weber